| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9954435 | Cancer Epidemiology | 2018 | 7 Pages |
Abstract
CT 1/cT2 and S I/II subgrouping is feasible to predict a different pT-category and a favorable WHO-grade (Gleason-Score) after RP, but failed to predict a different BFS. With the additional information of WHO-grade (Gleason-Score) and PSA, the PSG represents an approach for the prediction of all examined endpoints which is a useful tool to help clinicians to advise their patients.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jan Herden, Axel Heidenreich, Christian Wittekind, Lothar Weissbach,